title: Gluteal adipose-tissue polyunsaturated fatty-acids profiles and depressive symptoms in obese adults with obstructive sleep apnea hypopnea syndrome: a cross-sectional study.
abstract: Biomarkers of Polyunsaturated Fatty Acids (PUFAs) have been related to depressive symptoms in healthy adults. It is also known that depression is high prevalent in Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) and obesity. The aim of our study was to examine a possible association between PUFAs of the n-6 and n-3 families and depressive symptoms in obese OSAHS patients. Sixty three patients with OSAHS based on overnight attended polysomnography were included. Gluteal adipose tissue biopsies were performed in all participants. Fatty acids were analyzed by gas chromatography. Depressive symptoms were assessed by the Zung Self-rating Depression Scale. The majority of participants had grade II obesity (BMI: 36.2±4.3 kg/m(2)) and moderate to severe OSAHS. Mild depressive symptoms were found to affect 27.8% of the studied patients. No link between symptoms of depression and individual n-6 and/or n-3 PUFAs of gluteal adipose tissue was detected. However, multiple linear regression analysis showed a positive correlation between depressive symptoms and 20:3n-6/18:3n-6 ratio, and a negative association with age and n-6/n-3 ratio. The possible influence of OSAHS and obesity in depression development and the quiescent nature of gluteal adipose tissue may account for the absence of any significant relations between n-6 and/or n-3 PUFAs and depressive symptoms in our sample. The positive relationship between symptoms of depression and the particular fatty acid ratio probably indicates an increase in prostaglandins family although this needs further research.
authors.affiliation: Department of Social Medicine, Preventive Medicine and Nutrition Clinic, Medical School, University of Crete, Heraklion, Greece. papchris10@gmail.com
authors.forename: Christopher
authors.initials: C
authors.lastname: Papandreou
authors.forename: Sophia E
authors.initials: SE
authors.lastname: Schiza
authors.forename: George
authors.initials: G
authors.lastname: Tsibinos
authors.forename: Charalampos
authors.initials: C
authors.lastname: Mermigkis
authors.forename: Christos M
authors.initials: CM
authors.lastname: Hatzis
authors.forename: Anthony G
authors.initials: AG
authors.lastname: Kafatos
authors.forename: Nikolaos M
authors.initials: NM
authors.lastname: Siafakas
authors.forename: George A
authors.initials: GA
authors.lastname: Fragkiadakis
authors.forename: Nikolaos E
authors.initials: NE
authors.lastname: Tzanakis
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism*; D000328:Adult; D015415:Biomarkers / Q000378:metabolism; D002081:Buttocks; D003430:Cross-Sectional Studies; D003863:Depression / Q000150:complications* / Q000378:metabolism*; D015525:Fatty Acids, Omega-3 / Q000032:analysis / Q000378:metabolism; D043371:Fatty Acids, Omega-6 / Q000032:analysis / Q000378:metabolism; D005231:Fatty Acids, Unsaturated / Q000032:analysis / Q000737:chemistry / Q000378:metabolism*; D005260:Female; D006801:Humans; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000378:metabolism; D020181:Sleep Apnea, Obstructive / Q000150:complications* / Q000378:metabolism*; D055815:Young Adult
chemical_list: D015415:Biomarkers; D015525:Fatty Acids, Omega-3; D043371:Fatty Acids, Omega-6; D005231:Fatty Acids, Unsaturated